- AU$27.51m
- AU$34.60m
- AU$62.99m
Annual income statement for Medadvisor, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | R2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 40.3 | 67.8 | 98 | 98.4 | 63 |
| Cost of Revenue | |||||
| Gross Profit | 22.8 | 35 | 59.4 | 53.5 | 32.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 57.1 | 85.5 | 109 | 101 | 126 |
| Operating Profit | -16.8 | -17.7 | -10.6 | -2.21 | -63.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -17.2 | -17.7 | -10.5 | -2.21 | -63.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -14.4 | -17.5 | -11.3 | -2.34 | -63.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -13.9 | -17.3 | -11.3 | 0.792 | -60.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.9 | -17.3 | -11.3 | 0.792 | -60.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.044 | -0.046 | -0.021 | -0.004 | -0.053 |